GALECTO BIOTECH ApS: Financial statements 2014
CVR: 34878366
Source: annual report 2014, Danish Business Authority
01/01/2014 – 31/12/2014
GALECTO BIOTECH ApS (CVR 34878366) has filed annual accounts for 2014. In 2014, the company reported a gross profit of DKK -15,028,765 and a net result of DKK -11,988,254 compared with DKK -17,074,022 the year before. Equity in the 2014 report amounted to DKK -30,564,149.
- Gross Profit
- DKK -15,028,765
- Profit/Loss
- DKK -11,988,254
- Equity
- DKK -30,564,149
- Total Assets
- DKK 34,012,899
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2014 | - | -15 mio. | -12 mio. | -30.6 mio. | - |
| 2013 | - | -15 mio. | -17.1 mio. | -18.6 mio. | - |
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2014
GALECTO BIOTECH ApS has published its annual report for 2013. Gross profit came to DKK -14,954,230, and the net result was DKK -17,074,022.
About GALECTO BIOTECH ApS
GALECTO BIOTECH ApS is a Danish company of the type Anpartsselskab based in Frederiksberg, founded in 2012. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The management consists of Garrett Michael Winslow. The company is owned by Galecto Biotech AB. The company has 3 employees (2018). In 2025, the company reported a gross profit of EUR 1,039,275 and a net result of EUR -709,079 compared with EUR 310,297 the year before. Equity in the 2025 report amounted to EUR 7,844,625.